607
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Private sector availability and affordability of under 5 malaria health commodities in selected states in Nigeria and the Federal Capital Territory

ORCID Icon, , , , , , , , , & show all

References

  • Adejoro, L. (2023). Nigeria records 55 million malaria cases annually - FG. Punch Newspapers. https://punchng.com/nigeria-records-55-million-malaria-cases-annually-fg/.
  • Adeyi, O., & Atun, R. (2010). Universal access to malaria medicines: Innovation in financing and delivery. The Lancet, 376(9755), 1869–1871. doi:10.1016/S0140-6736(10)61189-0
  • Akulayi, L., Alum, A., Andrada, A., Archer, J., Arogundade, E. D., Auko, E., Tougher Sarah Hanson Kara Goodman Catherine, (2017). What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism. Malaria Journal, 16(1), 173. doi:10.1186/s12936-017-1814-z
  • Arnold, F., Ye, Y., Ren, R., Yoder, S., Hanson, K., Goodman, C., et al. (2012). AMFm independent evaluation team.
  • Dasgupta, R. R., Mao, W., & Ogbuoji, O. (2022). Addressing child health inequity through case management of under-five malaria in Nigeria: An extended cost-effectiveness analysis. Malaria Journal, 21(1), 81. doi:10.1186/s12936-022-04113-w
  • Ebere Emilia, A., Adaobi Uchenna, M., Jude Chidieber, O., Maxwell Ogochukwu, A., Chukwuemeka Michael, U., & Chinwe Victoria, U. (2021). Direct medical cost of treatment of uncomplicated malaria after the adoption of artemisinin-based combination therapy in Nigeria. Journal of Applied Pharmaceutical Science, 11(9), 29–34. doi:10.7324/JAPS.2021.110904
  • Edwards, H., Sarwar, R., Mahmud, P., Shekarau, E., Maxwell, K., & Tibenderana, J. (2022a). The private sector market for malaria rapid diagnostic tests in Nigeria: Results of the 2018 market survey. Malaria Journal, 21(190). doi:10.1186/s12936-022-04209-3
  • Edwards, H. M., Sarwar, R., Mahmud, P., Emmanuel, S., Maxwell, K., & Tibenderana, J. K. (2022b). The impact of the private sector co-payment mechanism (PSCM) on the private market for ACT in Nigeria: Results of the 2018 cross-sectional outlet and household market surveys. Malaria Journal, 21(1), 42. doi:10.1186/s12936-021-04039-9
  • Emmanuel Awucha, N., Chinelo Janefrances, O., Chima Meshach, A., Chiamaka Henrietta, J., Ibilolia Daniel, A., & Esther Chidiebere, N. (2020). Impact of the COVID-19 pandemic on consumers’ access to essential medicines in Nigeria. The American Journal of Tropical Medicine and Hygiene, 103(4), 1630–1634. doi:10.4269/ajtmh.20-0838
  • Ezenduka, C. C., Ogbonna, B. O., Ekwunife, O. I., Okonta, M. J., & Esimone, C. O. (2014). Drugs use pattern for uncomplicated malaria in medicine retail outlets in enugu urban: southeast Nigeria: Implications for malaria treatment policy. Malaria Journal, 13(1), 243. doi:10.1186/1475-2875-13-243
  • Ezenduka, C. C., Okonta, J., & Ogbonna, B. O. (2013). Survey of antimalarial drugs prices and availability in retail outlets in Enugu Urban South East Nigeria. Value in Health, 16(3), A96. doi:10.1016/j.jval.2013.03.451
  • Jha, P., Ambwani, S., Singh, S., Bhardwaj, P., Babu Varthya, S., & Charan, J. (2022). Availability of the essential medicines is community pharmacies: A cross-sectional study. Journal of Pharmacology and Pharmacotherapeutics, 13(1), 92–94. doi:10.1177/0976500X221080370
  • Joda, A., Ezeigwe, N., Oguguo, L., Taylor, O., & Ntadom, G. (2015). Effect of the affordable medicines facility for malaria (AMFm) on the availability of antimalarials in Nigeria. Malar World J, 6(5), 1–6, https://media.malariaworld.org/MWJ_2015_6_5_fbbee2753a.pdf
  • Kazancoglu, Y., Ekinci, E., Mangla, S. K., Sezer, M. D., & Ozbiltekin-Pala, M. (2023). Impact of epidemic outbreaks (COVID-19) on global supply chains: A case of trade between Turkey and China. Socio-Economic Planning Sciences, 85, 101494. doi:10.1016/j.seps.2022.101494
  • Lee, K. S., Kassab, Y. W., Taha, N. A., & Zainal, Z. A. (2021). Factors impacting pharmaceutical prices and affordability: Narrative review. Pharmacy, 9(1), 1. doi:10.3390/pharmacy9010001
  • Management Sciences for Health. (2021). The private sector has an important role to play in malaria elimination in Nigeria. Management Sciences for Health. https://msh.org/story/the-private-sector-has-an-important-role-to-play-in-malaria-elimination-in/.
  • Mogojwe, H. (2022). Sustaining a functioning market for malaria commodities. Clinton Health Access Initiative. https://www.clintonhealthaccess.org/research/sustaining-a-functioning-market-for-malaria-commodities/.
  • Moosavi, J., Fathollahi-Fard, A. M., & Dulebenets, M. A. (2022). Supply chain disruption during the COVID-19 pandemic: Recognizing potential disruption management strategies. International Journal of Disaster Risk Reduction, 75, 102983. doi:10.1016/j.ijdrr.2022.102983
  • Okonkwo, A., & Okonkwo, U. (2010). Patent medicine vendors,: community pharmacists and STI management in Abuja, Nigeria. African Health Sciences, 10(3), 253–265. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035963/
  • Okorosobo, T., Mwabu, G., Nabyonga-Orem, J., & Kirigia, J. (2011). Economic burden of malaria in six countries of Africa. J Bus Mark Manag, 3(6), 42-62, http://erepository.uonbi.ac.ke/handle/11295/78303.
  • Oladepo Oladimeji, Oyeyemi Abisoye S., Titiloye Musibau A., Adeyemi Adedayo O., Burnett Sarah M., Apera Iorwakwagh, Oladunni Opeyemi, Alliu Michael, (2019). Malaria testing and treatment knowledge among selected rural patent and proprietary medicine vendors (PPMV) in Nigeria. Malaria Journal, 18(1), 1–8. doi:10.1186/s12936-019-2732-z
  • Omogbolagun, T. (2021). 70% Nigerians get healthcare from private sector, says SFH. Punch Newspapers. https://punchng.com/70-nigerians-get-healthcare-from-private-sector-says-sfh/.
  • Oyeyemi, A., Oladepo, O., Adeyemi, A., Musibau Ayoade, T., Burnett, S., & Apera, I. (2020). The potential role of patent and proprietary medicine vendors’ associations in improving the quality of services in Nigeria’s drug shops. BMC Health Services Research, 20(1). doi:10.1186/s12913-020-05379-z
  • Poyer, S., Shewchuk, T., Tougher, S., Ye, Y., Mann, A. G., Willey, B. A., Thomson, R., Amuasi, J. H., Ren, R., Wamukoya, M., Taylor, M., Nguah, S. B., Mberu, B., Kalolella, A., Juma, E., Festo, C., Johanes, B., Diap, G., Bruxvoort, K., … Goodman, C. (2015). Availability and price of malaria rapid diagnostic tests in the public and private health sectors in 2011: Results from 10 nationally representative cross-sectional retail surveys. Tropical Medicine & International Health, 20(6), 744–756. doi:10.1111/tmi.12491
  • Raju PKS. Chapter 6.2 - WHO/HAI methodology for measuring medicine prices,: availability and affordability, and price components. In: Vogler S, editor. Medicine price surveys, analyses and comparisons. Academic Press; 2019. pp. 209–228. doi:10.1016/B978-0-12-813166-4.00012-7
  • Tougher, S., Ye, Y., Amuasi, J. H., Kourgueni, I. A., Thomson, R., Goodman, C., Mann, A. G., Ren, R., Willey, B. A., Adegoke, C. A., Amin, A., Ansong, D., Bruxvoort, K., Diallo, D. A., Diap, G., Festo, C., Johanes, B., Juma, E., Kalolella, A., … Hanson, K. (2012). Effect of the Affordable Medicines Facility—malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: A before-and-after analysis of outlet survey data. The Lancet, 380(9857), 1916–1926. doi:10.1016/S0140-6736(12)61732-2
  • Ugonna, C. (2014). Access to malaria diagnosis, treatment difficult for Nigeria’s poor-expert. Premium Times Nigeria. https://www.premiumtimesng.com/news/159542-access-malaria-diagnosis-treatment-difficult-nigerias-poor-expert.html.
  • Unitaid. (2021). Affordable medicines for malaria. Unitaid. https://unitaid.org/project/affordable-medicines-malaria/.
  • Wirtz, V. J., Kaplan, W. A., Kwan, G. F., & Laing, R. O. (2016). Access to medications for cardiovascular diseases in low- and middle-income countries. Circulation, 133(21), 2076–2085. doi:10.1161/CIRCULATIONAHA.115.008722
  • World Health Organization. (2012). Measuring medicine prices, availability, affordability and price components, 2nd edition. https://www.who.int/publications-detail-redirect/WHO-PSM-PAR-2008.3.
  • World Health Organization. (2021). Global technical strategy for malaria 2016-2030. https://www.who.int/publications-detail-redirect/9789240031357.
  • World Health Organization. (2022a). World malaria report 2022. https://www.who.int/publications-detail-redirect/9789240064898.
  • World Health Organization. (2022b). WHO Guidelines for malaria. https://www.who.int/teams/global-malaria-programme/guidelines-for-malaria.
  • World Health Organization. (2023). WHO Model List of Essential Medicines - 23rd list, 2023. https://www.who.int/publications-detail-redirect/WHO-MHP-HPS-EML-2023.02.
  • Ye, Y., Arnold, F., Noor, A., Wamukoya, M., Amuasi, J., Blay, S., Mberu, B., Ren, R., Kyobutungi, C., Wekesah, F., Gatakaa, H., Toda, M., Njogu, J., Evance, I., O’Connell, K., Shewchuk, T., Thougher, S., Mann, A., Willey, B., … Hanson, K. (2015). The Affordable Medicines Facility-malaria (AMFm): are remote areas benefiting from the intervention? Malaria Journal, 14(1), 398. doi:10.1186/s12936-015-0904-z
  • Yusuf, O. B., Adeoye, B. W., Oladepo, O. O., Peters, D. H., & Bishai, D. (2010). Poverty and fever vulnerability in Nigeria: A multilevel analysis. Malaria Journal, 9(1), 235. doi:10.1186/1475-2875-9-235